search
Back to results

The Complement Lectin Pathway After Cardiac Arrest

Primary Purpose

Out-of-Hospital Cardiac Arrest, Post Cardiac Arrest Syndrome

Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Targeted temperature management (33 degree Celsius)
Sponsored by
University of Aarhus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Out-of-Hospital Cardiac Arrest

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Out-of-Hospital Cardiac Arrest of presumed cardiac cause
  • Return of spontaneous circulation (ROSC)
  • Glasgow Coma Score < 8
  • Age > 18 years and < 80 years

Exclusion Criteria:

  • > 60 minutes from the circulatory collapse to ROSC
  • Time interval > 4 hours from cardiac arrest to initiation of targeted temperature management
  • Terminal illness
  • Coagulation disorder
  • Unwitnessed asystolia
  • Cerebral performance category 3-4 before the cardiac arrest
  • Severe persistent cardiogenic shock
  • Pregnancy
  • Persistent cardiogenic shock (systolic bloodpressure < 80 despite inotropic treatment)
  • New apoplexy or cerebral hemorrhage
  • Lack of consent from the relatives
  • Lack of consent from the general practitioner
  • Lack of consent from the patient

Sites / Locations

  • Department of Biomedicine, Aarhus University
  • Department of Anesthesiology and Intensive Care, Aarhus University Hospital
  • Department of Clinical Biochemistry, Aarhus University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

24 hour of targeted temperature management

48 hour of targeted temperature management

Arm Description

Patients resuscitated after cardiac arrest and treated with 24 hours of targeted temperature management (33 degree Celsius)

Patients resuscitated after cardiac arrest and treated with 48 hours of targeted temperature management (33 degree Celsius)

Outcomes

Primary Outcome Measures

MASP-2 concentration in plasma

Secondary Outcome Measures

MASP-2 concentration in plasma
MASP-2 concentration in plasma
MASP-2 concentration in plasma compared with 30-day mortality
MASP-2 concentration in plasma
MASP-1 concentration in plasma
MASP-1 concentration in plasma
MASP-1 concentration in plasma
MASP-1 concentration in plasma compared with 30-day mortality
MASP-3 concentration in plasma
MASP-3 concentration in plasma
MASP-3 concentration in plasma
MASP-3 concentration in plasma compared with 30-day mortality
Mannan-Binding-Lectin concentration in plasma
Mannan-Binding-Lectin concentration in plasma
Mannan-Binding-Lectin concentration in plasma
Mannan-Binding-Lectin concentration in plasma compared to 30-day mortality
MAp44 concentration in plasma
Map44 concentration in plasma
MAp44 concentration in plasma
MAp44 concentration in plasma compared with 30-day mortality
MAp19 concentration in plasma
MAp19 concentration in plasma
MAp19 concentration in plasma
MAp19 concentration in plasma compared with 30-day mortality
H-ficolin concentration in plasma
H-ficolin concentration in plasma
H-ficolin concentration in plasma
H-ficolin concentration in plasma compared with 30-day mortality
M-ficolin concentration in plasma
M-ficolin concentration in plasma
M-ficolin concentration in plasma
M-ficolin concentration in plasma compared with 30-day mortality
CL-L1 concentration in plasma
CL-L1 concentration in plasma
CL-L1 concentration in plasma
CL-L1 concentration in plasma compared with 30-day mortality

Full Information

First Posted
June 16, 2016
Last Updated
July 4, 2016
Sponsor
University of Aarhus
search

1. Study Identification

Unique Protocol Identification Number
NCT02826057
Brief Title
The Complement Lectin Pathway After Cardiac Arrest
Official Title
The Complement Lectin Pathway in Patients Resuscitated After Cardiac Arrest
Study Type
Interventional

2. Study Status

Record Verification Date
June 2016
Overall Recruitment Status
Unknown status
Study Start Date
February 2016 (undefined)
Primary Completion Date
July 2016 (Anticipated)
Study Completion Date
July 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study includes comatose survivors of out-of-hospital cardiac arrest treated with 24 hours or 48 hours of targeted temperature management. The overall aim is to evaluate the importance of plasma complement protein concentrations in patients resuscitated after out-of-hospital cardiac arrest and treated with 24 hours or 48 hours of targeted temperature management. The specific aim is to evaluate: the concentration of plasma lectin pathway proteins the first, second and third day after cardiac arrest the relation between concentration of plasma lectin pathway proteins and mortality if prolonged targeted temperature management influences the concentration of plasma lectin pathway proteins This study is a sub-study to the trial entitled: "Time-differentiated targeted temperature management (TTH48) (ClinicalTrials.gov Identifier: NCT01689077)" The following Complement Lectin Pathway proteins will be measured: Mannan-Binding-Lectin, M-ficolin, H-ficolin, CL-L1, MASP-1, MASP-2, MASP-3, MAp19 and MAp44.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Out-of-Hospital Cardiac Arrest, Post Cardiac Arrest Syndrome

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
82 (Actual)

8. Arms, Groups, and Interventions

Arm Title
24 hour of targeted temperature management
Arm Type
Active Comparator
Arm Description
Patients resuscitated after cardiac arrest and treated with 24 hours of targeted temperature management (33 degree Celsius)
Arm Title
48 hour of targeted temperature management
Arm Type
Experimental
Arm Description
Patients resuscitated after cardiac arrest and treated with 48 hours of targeted temperature management (33 degree Celsius)
Intervention Type
Other
Intervention Name(s)
Targeted temperature management (33 degree Celsius)
Primary Outcome Measure Information:
Title
MASP-2 concentration in plasma
Time Frame
48 hours
Secondary Outcome Measure Information:
Title
MASP-2 concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
MASP-2 concentration in plasma
Description
MASP-2 concentration in plasma compared with 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours
Title
MASP-2 concentration in plasma
Time Frame
24 hours to 72 hours
Title
MASP-1 concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
MASP-1 concentration in plasma
Time Frame
24 hours to 72 hours
Title
MASP-1 concentration in plasma
Description
MASP-1 concentration in plasma compared with 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours
Title
MASP-3 concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
MASP-3 concentration in plasma
Time Frame
24 hours to 72 hours
Title
MASP-3 concentration in plasma
Description
MASP-3 concentration in plasma compared with 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours
Title
Mannan-Binding-Lectin concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
Mannan-Binding-Lectin concentration in plasma
Time Frame
24 hours to 72 hours
Title
Mannan-Binding-Lectin concentration in plasma
Description
Mannan-Binding-Lectin concentration in plasma compared to 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours
Title
MAp44 concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
Map44 concentration in plasma
Time Frame
24 hours to 72 hours
Title
MAp44 concentration in plasma
Description
MAp44 concentration in plasma compared with 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours
Title
MAp19 concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
MAp19 concentration in plasma
Time Frame
24 hours to 72 hours
Title
MAp19 concentration in plasma
Description
MAp19 concentration in plasma compared with 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours
Title
H-ficolin concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
H-ficolin concentration in plasma
Time Frame
24 hours to 72 hours
Title
H-ficolin concentration in plasma
Description
H-ficolin concentration in plasma compared with 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours
Title
M-ficolin concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
M-ficolin concentration in plasma
Time Frame
24 hours to 72 hours
Title
M-ficolin concentration in plasma
Description
M-ficolin concentration in plasma compared with 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours
Title
CL-L1 concentration in plasma
Time Frame
24 hours, 48 hours and 72 hours
Title
CL-L1 concentration in plasma
Time Frame
24 hours to 72 hours
Title
CL-L1 concentration in plasma
Description
CL-L1 concentration in plasma compared with 30-day mortality
Time Frame
24 hours, 48 hours, 72 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Out-of-Hospital Cardiac Arrest of presumed cardiac cause Return of spontaneous circulation (ROSC) Glasgow Coma Score < 8 Age > 18 years and < 80 years Exclusion Criteria: > 60 minutes from the circulatory collapse to ROSC Time interval > 4 hours from cardiac arrest to initiation of targeted temperature management Terminal illness Coagulation disorder Unwitnessed asystolia Cerebral performance category 3-4 before the cardiac arrest Severe persistent cardiogenic shock Pregnancy Persistent cardiogenic shock (systolic bloodpressure < 80 despite inotropic treatment) New apoplexy or cerebral hemorrhage Lack of consent from the relatives Lack of consent from the general practitioner Lack of consent from the patient
Facility Information:
Facility Name
Department of Biomedicine, Aarhus University
City
Aarhus
ZIP/Postal Code
8000
Country
Denmark
Facility Name
Department of Anesthesiology and Intensive Care, Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
8200
Country
Denmark
Facility Name
Department of Clinical Biochemistry, Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
8200
Country
Denmark

12. IPD Sharing Statement

Learn more about this trial

The Complement Lectin Pathway After Cardiac Arrest

We'll reach out to this number within 24 hrs